lenalidomide has been researched along with Fracture, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kocoglu, M; Li, A; Nageshwar, M; Sanchez-Petitto, G; Singh, Z; Tkaczuk, KHR | 1 |
| Aoki, K; Arima, H; Imai, H; Ishikawa, T; Kato, A; Matsushita, A; Mori, M; Nagano, S; Ono, Y; Tabata, S; Takahashi, T; Takiuchi, Y; Yanagita, S | 1 |
2 other study(ies) available for lenalidomide and Fracture, Pathologic
| Article | Year |
|---|---|
An Unusual Cause of a Pathological Vertebral Fracture: Solitary Plasmacytoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Decompression, Surgical; Dexamethasone; Disease Progression; Female; Fractures, Compression; Fractures, Spontaneous; Humans; Humeral Fractures; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Laminectomy; Lenalidomide; Multiple Myeloma; Plasmacytoma; Positron-Emission Tomography; Spinal Cord Compression; Spinal Fractures; Spinal Neoplasms; Thoracic Vertebrae; Tomography, X-Ray Computed | 2020 |
Therapeutic effects of lenalidomide on hemorrhagic intestinal myeloma-associated AL amyloidosis.
Topics: Aged; Amyloid; Amyloidosis; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Bone Diseases; Boronic Acids; Bortezomib; Carpal Tunnel Syndrome; Dexamethasone; Disease Progression; Doxorubicin; Duodenal Diseases; Female; Femur Head; Fractures, Spontaneous; Gastrointestinal Hemorrhage; Hip Fractures; Humans; Jejunal Diseases; Lenalidomide; Melphalan; Multiple Myeloma; Osteolysis; Prednisolone; Pyrazines; Thalidomide; Vincristine | 2013 |